Introduction
The European Web Survey on Drugs collected data between March and April 2021 from people who use drugs, aged 18 or older, living in 21 EU and 9 non-EU countries. During this period the populations in many European countries were experiencing COVID-19-related lockdown or restrictions. Unless otherwise indicated, the data presented here refer to the 48469 respondents who reported having used at least one illicit drug in the 12 months prior to the survey (last 12 months use) and live in one of 21 EU countries covered by the survey and Switzerland (1).
Click here for more information on the methodology of the European Web Survey on Drugs.
In summary
- Most survey respondents (93 %) reported using cannabis during the previous 12 months, 35 % used MDMA/ecstasy, 35 % cocaine and 28 % amphetamine.
- The most commonly reported motivations for cannabis use were relaxation, getting high and aiding sleep.
- Home was reported as the most common setting for drug use during the period.
- The impact of the COVID-19 pandemic and national measures was reported to be greatest on the use of cannabis (increased consumption) and ecstasy/MDMA (decreased consumption).
